RESEARCH BRIEF Resource navigation challenges for patients and caregivers While the problem of finding system-wide, implementable precision financing models for curative and durable therapies involves all stakeholders, patients and caregivers … Read More
The NEWDIGS Initiative at MIT welcomes Cerevel Therapeutics as a new collaborator on the LEAPS Project
Collaboration to enhance the capacity of disease ecosystems for regimen optimization CAMBRIDGE, MA November 25, 2020 – Cerevel Therapeutics, a company dedicated to unraveling the mysteries of the brain to treat … Read More
LEAPS Monthly Recap: December 2020
NEW MEMBER NEWDIGS welcomes Cerevel Therapeutics as a new collaborator on the LEAPS Project Collaboration to enhance the capacity of disease ecosystems for regimen optimization Cerevel Therapeutics, a company dedicated … Read More
FoCUS Monthly Recap: December 2020
IN THE MEDIAMark Trusheim coauthored the article “Market access of gene therapies across Europe, USA, and Canada: challenges, trends, and solutions” published in Science Direct: Drug Discovery Today, November 24, 2020. This review … Read More
Downstream Innovation: Designing infrastructures and environments for real-world disease-focused learning
The LEAPS Project is advancing sustainable, patient-centered biomedical innovation through a new collaborative systems approach to the planning, production, and use of real-world evidence at the level of disease, not … Read More
FoCUS Monthly Recap: October 2020
WHITE PAPER Warranty Model: A potential precision financing solution for durable cell and gene therapies Durable cell and gene therapies are poised for rapid growth—posing transformative benefits for patients and … Read More
LEAPS Monthly Recap: October 2020
RESEARCH SPOTLIGHT Downstream Innovation: Designing infrastructures and environments for real-world disease-focused learning The LEAPS Project is advancing sustainable, patient-centered biomedical innovation through a new collaborative systems approach to the planning, … Read More
Warranty Model: A potential precision financing solution for durable cell and gene therapies
Durable cell and gene therapies are poised for rapid growth – potentially providing transformative benefits for patients and exacerbating financial challenges for payers, providers, patients, and therapeutic developers. With five … Read More
Dynamic Dossier in the Cloud: A Sociotechnical Architecture for a Real-Time and Metrics-Based Data Tracking System with Gene and Cell Therapies as a Case Study
Published on October 28th in Therapeutic Innovation & Regulatory Science, the article addresses inefficiencies in the system and process of data sharing among stakeholders in the development, access, and use … Read More
NEWDIGS cohosts Virtual Design Labs on Efficacy to Effectiveness (E2E) and N-of-1 study design
On Tuesday, September 29th and Friday, October 23rd, the NEWDIGS team joined the Tufts Clinical and Translational Science Institute (CTSI) and the Johns Hopkins/Tufts Trial Innovation Network (TIN) in co-hosting … Read More